Network medicine: A network-based approach to human disease

Nature Reviews Genetics

Volumn 12, Issue 1, 2011, Pages 56-68

  Barabási, Albert László ^a,b,c   Gulbahce, Natali ^a,b,d   Loscalzo, Joseph ^c  

^a NORTHEASTERN UNIVERSITY   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; COMORBIDITY; DISEASE CLASSIFICATION; GENE MAPPING; GENE MUTATION; GENETIC DISORDER; HUMAN; HUMAN CELL; HUNTINGTON DISEASE LIKE SYNDROME; NERVE CELL NETWORK; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SCHIZOPHRENIA; SPINOCEREBELLAR DEGENERATION;

DATABASES, GENETIC; DISEASE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; METABOLIC NETWORKS AND PATHWAYS;

EID: 78650373804     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg2918     Document Type: Review

References (131)

1. Zhao, Y. & Jensen, O. N. Modification-specific proteomics: strategies for characterization of post-translational modifications using enrichments techniques. Proteomics 9, 4632-4641 (2009).
2. Venkatesan, K. et al. An empirical framework for binary interactome mapping. Nature Methods 6, 83-90 (2008).
3. Goldstein, D. B. Common genetic variation and human traits. N. Engl. J. Med. 360, 1696-1698 (2009).
4. Schadt, E. E. Molecular networks as sensors and drivers of common human diseases. Nature 461, 218-223 (2009).
5. Barabási, A.-L. Network medicine - from obesity to the "diseasome". N. Engl. J. Med. 357, 404-407 (2007).
6. Pawson, T. & Linding, R. Network medicine. FEBS Lett. 582, 1266-1270 (2008).
7. Zanzoni, A., Soler-López, M. & Aloy, P. A network medicine approach to human disease. FEBS Lett. 583, 1759-1765 (2009).
8. Ideker, T. & Sharan, R. Protein networks in disease. Genome Res. 18, 644-652 (2008).
9. Rual, J.-F. et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 437, 1173-1178 (2005).
10. Stelzl, U. et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell 122, 957-968 (2005).
11. Jeong, H. et al. The large-scale organization of metabolic networks. Nature 407, 651-654 (2000).
12. Fell, D. A. & Wagner, A. The small world of metabolism. Nature Biotech. 18, 1121-1122 (2000).
13. Duarte, N. C. et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc. Natl Acad. Sci. USA 104, 1777-1782 (2007).
14. Carninci, P. et al. The transcriptional landscape of the mammalian genome. Science 309, 1559-1563 (2005).
15. Linding, R. et al. NetworKIN: a resource for exploring cellular phosphorylation networks. Nucleic Acids Res. 36, D695-D699 (2008).
16. Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microrna targets. Cell 120, 15-20 (2005).
17. Reynolds, A. et al. Rational siRNA design for RNA interference. Nature Biotech. 22, 326-330 (2004).
18. Stuart, J. M. et al. A Gene-coexpression network for global discovery of conserved genetic modules. Science 302, 249-255 (2003).
19. Boone, C., Bussey, H. & Andrews, B. J. Exploring genetic interactions and networks with yeast. Nature Rev. Genet. 8, 437-449 (2007).
20. Beltrao, P., Cagney, G. & Krogan, N. Quantitative genetic interactions reveal biological modularity. Cell 141, 739-745 (2010).
21. Reverter, A., Ingham, A. & Dalrymple, B. P. Mining tissue specificity, gene connectivity and disease association to reveal a set of genes that modify the action of disease causing genes. BioData Min. 1, 8 (2008).
22. Lage, K. et al. A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexes. Proc. Natl Acad. Sci. USA 105, 20870-20875 (2008).
23. Lage, K. et al. Dissecting spatio-temporal protein networks driving human heart development and related disorders. Mol. Syst. Biol. 6, 381 (2010).
24. Schwartz, A. S., Yu, J., Gardenour, K. R., Finley, R. L. & Ideker, T. Cost-effective strategies for completing the interactome. Nature Methods 6, 55-61 (2009).
25. Yu, H. et al. High-quality binary protein interaction map of the yeast interactome network. Science 322, 104-110 (2008).
26. Kirouac, D. et al. Dynamic interaction networks in a hierarchically organized tissue. Mol. Syst. Biol. 6, 417 (2010).
27. Barabási, A.-L. & Oltvai, Z. Network biology: understanding the cell's functional organization. Nature Rev. Genet. 5, 101-113 (2004).
28. Albert, R. & Barabási, A.-L. Statistical mechanics of complex networks. Rev. Mod. Phys. 74, 47-97 (2002).
29. Zhu, X., Gerstein, M. & Snyder, M. Getting connected: analysis and principles of biological networks. Genes Dev. 21, 1010-1024 (2007).
30. Caldarelli, G. Scale Free Networks (Oxford Univ. Press, UK, 2007).
31. Albert, R. Scale-free networks in cell biology. J. Cell Sci. 11 8, 4947-4957 (2005).
32. Newman, M., Barabási, A.-L. & Watts, D. J. The Structure and Dynamics of Networks (Princeton Univ. Press, USA, 2006).
33. Amberger, J., Bocchini, C. A., Scott, A. F. & Hamosh, A. McKusick's Online Mendelian Inheritance in Man (OMIM®). Nucleic Acids Res. 37, D793-D796 (2009).
34. Jeong, H. et al. Lethality and centrality in protein networks. Nature 411, 41-42 (2001).
35. Fraser, H. B. et al. Evolutionary rate in the protein interaction network. Science 296, 750-752 (2002).
36. Eisenberg, E. & Levanon, E. Y. Preferential attachment in the protein network evolution. Phys. Rev. Lett. 91, 138701 (2003).
37. Saeed, R. & Deane, C. M. Protein protein interactions, evolutionary rate, abundance and age. BMC Bioinformatics 7, 128 (2006).
38. Jordan, I. K., Wolf, Y. I. & Koonin, E. V. No simple dependence between protein evolution rate and the number of protein-protein interactions: only the most prolific interactors tend to evolve slowly. BMC Evol. Biol. 3, 5 (2003).
39. Wachi, S., Yoneda, K. & Wu, R. Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues. Bioinformatics 21, 4205-4208 (2005).
40. Jonsson, P. F. & Bates, P. A. Global topological features of cancer proteins in the human interactome. Bioinformatics 22, 2291-2297 (2006).
41. Xu, J. & Li, Y. Discovering disease-genes by topological features in human protein-protein interaction network. Bioinformatics 22, 2800-2805 (2006).
42. Goh, K.-I. et al. The human disease network. Proc. Natl Acad. Sci. USA 104, 8685-8690 (2007).
43. Feldman, I., Rzhetsky, A. & Vitkup, D. Network properties of genes harboring inherited disease mutations. Proc. Natl Acad. Sci. USA 105, 4323-4328 (2008).
44. Hartwell, L. H., Hopfield, J. J. & Murray, A. W. From molecular to modular cell biology. Nature 402, C47-C52 (1999).
45. Oti, M. et al. Predicting disease genes using protein-protein interactions. J. Med. Genet. 43, 691-698 (2006).
46. Gandhi, T. et al. Analysis of the human protein interactome and comparison with yeast, worm and fly interaction datasets. Nature Genet. 38, 285-293 (2006).
47. Girvan, M. & Newman, M. E. Community structure in social and biological networks. Proc. Natl Acad. Sci. USA 99, 7821-7826 (2002).
48. Palla, G., Derényi, I., Farkas, I. & Vicsek, T. Uncovering the overlapping community structure of complex networks in nature and society. Nature 435, 814-818 (2005).
49. Ahn, Y.-Y., Bagrow, J. P. & Lehmann, S. Link communities reveal multiscale complexity in networks. Nature 466, 761-764 (2010).
50. Enright, A. J., Van Dongen, S. & Ouzounis, C. A. An efficient algorithm for large-scale detection of protein families. Nucleic Acids Res. 30, 1575-1584 (2002).
51. Ravasz, E., Somera, A. L., Mongru, D. A., Oltvai, Z. N. & Barabási, A.-L. Hierarchical organization of modularity in metabolic networks. Science 297, 1551-1555 (2002).
52. Wood, L. D. et al. The genomic landscapes of human breast and colorectal cancers. Science 318, 1108-1113 (2007).
53. Hirschhorn, J. N. Genomewide association studies - illuminating biologic pathways. N. Engl. J. Med. 360, 1699-1701 (2009).
54. Krauthammer, M. et al. Molecular triangulation: bridging linkage and molecular-network information for identifying candidate genes in Alzheimer's disease. Proc. Natl Acad. Sci. USA 101, 15148-15153 (2004).
55. Franke, L. et al. Reconstruction of a functional human gene network, with an application for prioritizing positional candidate genes. Am. J. Hum. Genet. 78, 1011-1025 (2006).
56. Iossifov, I., Zheng, T., Baron, M., Gilliam T. C. & Rzhetsky, A. Genetic-linkage mapping of complex hereditary disorders to a whole-genome molecular-interaction network. Genome Res. 18, 1150-1162 (2008).
57. Navlakha, S. & Kingsford, C. The power of protein interaction networks for associating genes with diseases. Bioinformatics 26, 1057-1063 (2010).
58. Lage, K. et al. A human phenome-interactome network of protein complexes implicated in genetic disorders. Nature Biotech. 25, 309-316 (2007).
59. Lee, E. et al. Analysis of AML genes in dysregulated molecular networks. BMC Bioinformatics 10, S2 (2009).
60. Bonifaci, N. et al. Biological processes, properties and molecular wiring diagrams of candidate low-penetrance breast cancer susceptibility genes. BMC Med. Genomics 1, 62 (2008).
61. Heiser, L. M. et al. Integrated analysis of breast cancer cell lines reveals unique signaling pathways. Genome Biol. 10, R31 (2009).
62. Chuang, H.-Y. et al. Network-based classification of breast cancer metastasis. Mol. Syst. Biol. 3, 140 (2007).
63. Nibbe, R. K. et al. Discovery and scoring of protein interaction subnetworks discriminative of late stage human colon cancer. Mol. Cell. Proteomics 8, 827-845 (2009).
64. Chang, W. et al. Identification of novel hub genes associated with liver metastasis of gastric cancer. Int. J. Cancer 125, 2844-2853 (2009).
65. Ergün, A., Lawrence, C. A., Kohanski, M. A., Brennan, T. A. & Collins, J. J. A network biology approach to prostate cancer. Mol. Syst. Biol. 3, 82 (2007).
66. Taylor, I. W. et al. Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nature Biotech. 27, 199-204 (2009).
67. Moran, L. B. & Graeber, M. B. Towards a pathway definition of Parkinson's disease: a complex disorder with links to cancer, diabetes and inflammation. Neurogenetics 9, 1-13 (2008).
68. Ray, M., Ruan, J. & Zhang, W. Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases. Genome Biol. 9, R148 (2008).
69. Hwang, D. et al. A systems approach to prion disease. Mol. Syst. Biol. 5, 252 (2009).
70. Wheelock, C. E. et al. Systems biology approaches and pathway tools for investigating cardiovascular disease. Mol. Biosyst. 5, 588-602 (2009).
71. Calvano, S. E. et al. A network-based analysis of systemic inflammation. Nature 437, 1032-1037 (2005).
72. Iliopoulos, D. et al. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS ONE 3, e3740 (2008).
73. Chen, Y. et al. Variations in DNA elucidate molecular networks that cause disease. Nature 452, 429-435 (2008).
74. Emilsson, V. et al. Genetics of gene expression and its effect on disease. Nature 452, 423-428 (2008).
75. Dobrin, R. et al. Multi-tissue coexpression networks reveal unexpected subnetworks associated with disease. Genome Biol. 10, R55 (2009).
76. Hwang, S. et al. A protein interaction network associated with asthma. J. Theor. Biol. 252, 722-731 (2008).
77. Liu, M. et al. Network-based analysis of affected biological processes in type 2 diabetes models. PLoS Genet. 3, e96 (2007).
78. Presson, A. P. et al. Integrated weighted gene co-expression network analysis with an application to chronic fatigue syndrome. BMC Syst. Biol. 2, 95 (2008).
79. Uetz, P. et al. Herpesviral protein networks and their interaction with the human proteome. Science 311, 239-242 (2006).
80. Calderwood, M. A. et al. Epstein-Barr virus and virus human protein interaction maps. Proc. Natl Acad. Sci. USA 104, 7606-7611 (2007).
81. Bordbar, A., Lewis, N. E., Schellenberger, J., Palsson, B. Ø. & Jamshidi, N. Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructions. Mol. Syst. Biol. 6, 422 (2010).
82. Turnbaugh, P. J. & Gordon, J. I. An invitation to the marriage of metagenomics and metabolomics. Cell 134, 708-713 (2008).
83. Goehler, H. et al. A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. Mol. Cell 15, 853-865 (2004).
84. Lim, J. et al. A Protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 125, 801-814 (2006).
85. Pujana, M. A. et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nature Genetics 39, 1338-1349 (2007).
86. Camargo, L. M. et al. Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Mol. Psychiatry 12, 74-86 (2007).
87. Amino, T. et al. Redefining the disease locus of 16q22.1-linked autosomal dominant cerebellar ataxia. J. Hum. Genet. 52, 643-649 (2007).
88. Kohler, S. et al. Walking the interactome for prioritization of candidate disease genes. Am. J. Hum. Genet. 82, 949-958 (2008).
89. Vanunu, O. et al. Associating genes and protein complexes with disease via network propagation. PLoS Comput. Biol. 6, e1000641 (2010).
90. Park, J. et al. The impact of cellular networks on disease comorbidity. Mol. Syst. Biol. 5, 262 (2009).
91. Dudley, A. M., Janse, D. M., Tanay, A., Shamir, R. & Church, G. M. A global view of pleiotropy and phenotypically derived gene function in yeast. Mol. Syst. Biol. 1, 1 (2005).
92. Zhong, Q. et al. Edgetic perturbation models of human inherited disorders. Mol. Syst. Biol. 5, 321 (2009).
93. Lee, D.-S. et al. The implications of human metabolic network topology for disease comorbidity. Proc. Natl Acad. Sci. USA 105, 9880-9885 (2008).
94. Lu, M. et al. An analysis of human microRNA and disease associations. PLoS ONE 3, e3420 (2008).
95. Rzhetsky, A. et al. Probing genetic overlap among complex human phenotypes. Proc. Natl Acad. Sci. USA 104, 11694-11699 (2007).
96. Hidalgo, C. et al. A dynamic network approach for the study of human phenotypes. PLoS Comput. Biol. 5, e1000353 (2009).
97. Van Driel, M. A. et al. A text-mining analysis of the human phenome. Eur. J. Hum. Genet. 14, 535-542 (2006).
98. Suthram, S. et al. Network-based elucidation of human disease network-based elucidation of human disease enriched for pluripotent drug targets. PLoS Comput. Biol. 6, e1000662 (2010).
99. Liu, Y. I., Wise, P. H. & Butte, A. J. The "etiome": identification and clustering of human disease etiological factors. BMC Bioinformatics 10, S14 (2009).
100. Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J. & Bork, P. Drug target identification using side-effect similarity. Science 321, 263-266 (2008).
101. Kuhn, M., Campillos, M, Letunic, I, Jensen, L. J. & Bork, P. A side effect resource to capture phenotypic effects of drugs. Mol. Syst. Biol. 6, 343 (2010).
102. Audouze, K. et al. Deciphering diseases and biological targets. for environmental chemicals using toxicogenomics networks. PLoS Comput. Biol. 6, e1000788 (2010).
103. Schadt, E. E., Friend, S. H. & Shaywitz, D. A. A network view of disease and compound screening. Nature Rev. Drug Disc. 8, 286-295 (2009).
104. Hopkins, A. L. Drug discovery: predicting promiscuity. Nature 462, 167-168 (2009).
105. Chu, L. & Chen, B. S. Construction of a cancer-perturbed protein-protein interaction network for discovery of apoptosis drug targets. BMC Syst. Biol. 2, 56 (2008).
106. Azmi, A., Wang, Z., Philip, P. A., Mohammad, R. M. & Sarkar, F. H. Proof of concept: a review on how network and systems biology approaches aid in the discovery of potent anticancer drug combinations. Mol. Cancer Ther. 1 Nov 2010 (doi:10.1158/1535-7163.MCT-10-0642).
107. Zhao, S. & Li, S. Network-based relating pharmacological and genomic spaces for drug target identification. PLoS ONE 5, e11764 (2010).
108. Fong, S. S. & Palsson, B. Ø. Metabolic gene-deletion strains of Escherichia coli evolve to computationally predicted growth phenotypes. Nature Genet. 36, 1056-1058 (2004).
109. Segrè, D., Vitkup, D. & Church, G. M. Analysis of optimality in natural and perturbed metabolic networks. Proc. Natl Acad. Sci. USA 99, 15112-15117 (2002).
110. Shen, Y. et al. Blueprint for antimicrobial hit discovery targeting metabolic networks. Proc. Natl Acad. Sci. USA 107, 1082-1087 (2010).
111. Motter, A. E., Gulbahce, N., Almaas, E. & Barabási, A.-L. Predicting synthetic rescues in metabolic networks. Mol. Syst. Biol. 4, 168 (2008).
112. Nolan, G. P. What's wrong with drug screening today. Nature Chem. Biol. 3, 187-191 (2007).
113. Csermely, P., Agoston, V. & Pongor, S. The efficiency of multi-target drugs: the network approach might help drug design. Trends Pharmacol. Sci. 26, 178-182 (2005).
114. Motter, A. E. Improved network performance via antagonism: from synthetic rescues to multi-drug combinations. Bioessays 32, 236-245 (2010).
115. Yang, K. et al. Finding multiple target optimal intervention in disease related molecular network. Mol. Syst. Biol. 4, 228 (2008).
116. Vazquez, A. Optimal drug combinations and minimal hitting sets. BMC Syst. Biol. 3, 81 (2009).
117. Yildirim, M. A. et al. Drug-target network. Nature Biotech. 25, 1119-1126 (2007).
118. Keiser, M. J. et al. Predicting new molecular targets for known drugs. Nature 462, 175-181 (2009).
119. Ho, C. Y. & Seidman, C. E. A contemporary approach to hypertrophic cardiomyopathy. Circulation 11 3, e858-e862 (2006).
120. Morita, Y. et al. Shared genetic causes of cadiac hypertrophy in children and adults. N. Engl. J. Med. 358, 1899-1908 (2008).
121. Loscalzo, J., Kohane, I., Barabási, A.-L. Human disease classification in the postgenomic era: a complex systems approach to human pathobiology. Mol. Syst. Biol. 3, 124 (2007).
122. Dreze, M. et al. High-quality binary interactome mapping. Meth. Enzymol. 470, 281-315 (2010).
123. Ewing, R. M. et al. Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol. Syst. Biol. 3, 89 (2007).
124. Cusick, M. E. et al. Literature-curated protein interaction datasets. Nature Methods 6, 39-46 (2009).
125. Ma, H. et al. The Edinburgh human metabolic network reconstruction and its functional analysis. Mol. Syst. Biol. 3, 135 (2007).
126. Barabási, A.-L. & Albert, R. Emergence of scaling in random networks. Science 286, 509-512 (1999).
127. Han, J. D. et al. Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature 430, 88-93 (2004).
128. Watts, D. J. & Strogatz, S. H. Collective dynamics of 'small-world' networks. Nature 393, 440-442 (1998).
129. Milo, R., Shen-Orr, S., Itzkovitz, S., Kashtan, N., Chklovskii, D. & Alon, U. Network motifs: simple building blocks of complex networks. Science 298, 824-827 (2002).
130. Yu, H., Kim, P. M., Sprecher, E., Trifonov, V. & Gerstein, M. The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics. PLoS Comput. Biol. 3, e59 (2007).
131. Wu, X., Jiang, R., Zhang, M. Q. & Li, S. Network-based global inference of human disease genes. Mol. Syst. Biol. 4, 189 (2008).